$1.08
0.011.40%
At close: -
$1.05
-0.03-3.23%
After Hours: Apr 11, 7:21 PM EDT
Comments
Loading...
OKYO Pharma (OKYO) Forecast
NewsEarningsOKYO Pharma (OKYO) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
OKYO Pharma Stock Price, Quotes and Forecasts | NASDAQ:OKYO | Benzinga
Explore OKYO Pharma stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for OKYO.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy OKYO Pharma (OKYO) stock?
You can purchase shares of OKYO Pharma (NASDAQ:OKYO) through any online brokerage.
Who are OKYO Pharma (OKYO) competitors?
Other companies in OKYO Pharma’s space includes: Fortress Biotech (NASDAQ:FBIO), Connect Biopharma Hldgs (NASDAQ:CNTB), PepGen (NASDAQ:PEPG), Armata Pharmaceuticals (AMEX:ARMP) and FibroBiologics (NASDAQ:FBLG).
What is the forecast, or price target, for OKYO Pharma (OKYO) stock?
OKYO Pharma has a consensus price target of $7.00.
What is the current price for OKYO Pharma (OKYO)?
The stock price for OKYO Pharma (NASDAQ: OKYO) is $1.05 last updated April 11, 2025 at 7:21 PM EDT.
Does OKYO Pharma (OKYO) pay a dividend?
There are no upcoming dividends for OKYO Pharma.
When is OKYO Pharma (NASDAQ:OKYO) reporting earnings?
OKYO Pharma’s H1 earnings are confirmed for Friday, April 25, 2025.
Is OKYO Pharma (OKYO) going to split?
There is no upcoming split for OKYO Pharma.
What sector and industry does OKYO Pharma (OKYO) operate in?
OKYO Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.